Pembrolizumab plus axitinib for metastatic papillary and chromophobe kidney cancer
Non-clear cell kidney cancer is a group of different subtypes [...]
Non-clear cell kidney cancer is a group of different subtypes [...]
In this study, real world data is used to compare [...]
A recent paper published in The Oncologist has shown that [...]
At the 2023 Society of Urologic Oncology (SUO) Annual Meeting, [...]
The National Institute for Health and Care Excellence (NICE) has [...]
This study looked at real world information from patients with [...]
This phase 2 study looked at the effect on survival [...]
When ipilimumab plus nivolumab or axitinib plus pembrolizumab are used [...]
In this phase 3b/4 study, people with advanced kidney cancer [...]
A biomarker is a biological molecule found in blood, other body [...]